NM_000484.4:c.663-5084A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000484.4(APP):​c.663-5084A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.1 in 152,204 control chromosomes in the GnomAD database, including 1,200 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1200 hom., cov: 32)

Consequence

APP
NM_000484.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.988

Publications

6 publications found
Variant links:
Genes affected
APP (HGNC:620): (amyloid beta precursor protein) This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]
APP Gene-Disease associations (from GenCC):
  • Alzheimer disease type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • cerebral amyloid angiopathy, APP-related
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ABeta amyloidosis, Arctic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, dutch type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Iowa type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Italian type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaA21G amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaL34V amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset autosomal dominant Alzheimer disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APPNM_000484.4 linkc.663-5084A>G intron_variant Intron 5 of 17 ENST00000346798.8 NP_000475.1 P05067-1A0A140VJC8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APPENST00000346798.8 linkc.663-5084A>G intron_variant Intron 5 of 17 1 NM_000484.4 ENSP00000284981.4 P05067-1

Frequencies

GnomAD3 genomes
AF:
0.100
AC:
15219
AN:
152086
Hom.:
1192
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.163
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.174
Gnomad ASJ
AF:
0.0159
Gnomad EAS
AF:
0.287
Gnomad SAS
AF:
0.136
Gnomad FIN
AF:
0.102
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0342
Gnomad OTH
AF:
0.0809
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.100
AC:
15247
AN:
152204
Hom.:
1200
Cov.:
32
AF XY:
0.106
AC XY:
7896
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.162
AC:
6735
AN:
41506
American (AMR)
AF:
0.175
AC:
2675
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0159
AC:
55
AN:
3470
East Asian (EAS)
AF:
0.288
AC:
1491
AN:
5172
South Asian (SAS)
AF:
0.136
AC:
655
AN:
4820
European-Finnish (FIN)
AF:
0.102
AC:
1077
AN:
10606
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0342
AC:
2328
AN:
68018
Other (OTH)
AF:
0.0834
AC:
176
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
652
1305
1957
2610
3262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0686
Hom.:
89
Bravo
AF:
0.113
Asia WGS
AF:
0.215
AC:
746
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.24
DANN
Benign
0.38
PhyloP100
-0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2211772; hg19: chr21-27399442; API